PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+42.22%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.47B
AUM Growth
+$29.3M
(+0.85%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
46.93%
Holding
128
New
11
Increased
20
Reduced
25
Closed
30
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$116M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$109M |
| 3 |
Vaxcyte
PCVX
|
$56.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$51.3M |
| 5 |
Acrivon Therapeutics
ACRV
|
$34.7M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$158M |
| 2 |
Relmada Therapeutics
RLMD
|
$88.2M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$43.3M |
| 4 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$28.1M |
| 5 |
Edwards Lifesciences
EW
|
$27.3M |
Sector Composition
| 1 | Healthcare | 100% |